ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Voyager Therapeutics, Inc. ?
1
The company has declared Negative results for the last 5 consecutive quarters
- NET SALES(HY) At USD 18.57 MM has Grown at -65.75%
- NET PROFIT(HY) At USD -61.27 MM has Grown at -219.38%
- OPERATING CASH FLOW(Y) Lowest at USD -116.74 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 0.26%, its profits have fallen by -589.9%
3
Underperformed the market in the last 1 year
- The stock has generated a return of 0.26% in the last 1 year, much lower than market (S&P 500) returns of 13.68%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Voyager Therapeutics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Voyager Therapeutics, Inc.
3.07%
-0.78
70.81%
S&P 500
13.68%
0.71
19.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-30.79%
EBIT Growth (5y)
-230.29%
EBIT to Interest (avg)
-10.21
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.84
Sales to Capital Employed (avg)
0.49
Tax Ratio
0.82%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
70.80%
ROCE (avg)
0
ROE (avg)
14.16%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.17
EV to EBIT
-0.40
EV to EBITDA
-0.41
EV to Capital Employed
3.01
EV to Sales
1.80
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-748.07%
ROE (Latest)
-57.67%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET PROFIT(HY)
Higher at USD -61.27 MM
NET SALES(Q)
At USD 13.37 MM has Grown at 25.55%
-22What is not working for the Company
NET SALES(HY)
At USD 18.57 MM has Grown at -65.75%
NET PROFIT(HY)
At USD -61.27 MM has Grown at -219.38%
OPERATING CASH FLOW(Y)
Lowest at USD -116.74 MM
ROCE(HY)
Lowest at -46.09%
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.64 times
Here's what is working for Voyager Therapeutics, Inc.
Net Profit
Higher at USD -61.27 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Sales
At USD 13.37 MM has Grown at 25.55%
over average net sales of the previous four periods of USD 10.65 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Here's what is not working for Voyager Therapeutics, Inc.
Net Profit
At USD -61.27 MM has Grown at -219.38%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Cash Flow
Lowest at USD -116.74 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Debtors Turnover Ratio
Lowest at 2.64 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
